UBS Group Upgrades Option Care Health (NASDAQ:OPCH) to Buy
Option Care Health (NASDAQ:OPCH – Get Free Report) was upgraded by UBS Group from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, Marketbeat reports. The firm currently has a $40.00 price target on the stock, up from their previous price target of $38.00. UBS Group’s price objective would suggest […]
Option Care Health (NASDAQ:OPCH – Get Free Report) was upgraded by UBS Group from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, Marketbeat reports. The firm currently has a $40.00 price target on the stock, up from their previous price target of $38.00. UBS Group’s price objective would suggest […]
